Published in Immunotherapy Weekly, May 26th, 2010
"Data from a 2-year postintervention follow-up were assessed to determine whether there were longer-term effects on the asthma status and quality of life...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Immunotherapy Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.